COVID-19 Vaccination Bests Natural Immunity for Cutting Death, Hospitalizations

WEDNESDAY, Dec. 28, 2022 (HealthDay News) -- Compared with individuals with natural COVID-19 immunity from previous infection, individuals who are vaccinated have lower rates of all-cause emergency department visits, hospitalizations, and mortality, according to a study published in the January issue of the American Journal of Public Health.
Wanzhu Tu, Ph.D., from the Indiana University School of Medicine in Indianapolis, and colleagues compared the cumulative incidence of infection, all-cause emergency department visits, hospitalizations, and mortality among 267,847 matched pairs of individuals who received at least one COVID-19 vaccine dose and individuals with previous severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.
The researchers found that six months after the index date, the incidence of SARS-CoV-2 infection was significantly higher in vaccine recipients (6.7 percent) than in those previously infected (2.9 percent). However, among the vaccinated individuals, all-cause mortality was 37 percent lower than that of the previously infected. Similarly, the rates of all-cause emergency department visits and hospitalizations were 24 and 37 percent lower, respectively, in the vaccinated than in the previously infected individuals.
"The significantly lower rates of all-cause emergency department visits, hospitalizations, and mortality in the vaccinated highlight the real-world benefits of vaccination," the authors write. "The data raise questions about the wisdom of reliance on natural immunity when safe and effective vaccines are available."
Related Posts
Filadelfia es la primera ciudad de EE. UU. que restaura la obligatoriedad de las máscaras en interiores
MARTES, 12 de abril de 2022 (HealthDay News) -- Ante los crecientes conteos de...
Omicron Silver Lining: Fewer, Milder Cases of MIS-C in Kids
MONDAY, Jan. 23, 2023 (HealthDay News) -- The COVID-19 Omicron variant caused...
New Tests for Colon, Prostate Cancer Show Promise
WEDNESDAY, Sept. 29, 2021 (HealthDay News) -- A pair of experimental tests could...
La FDA y una compañía se enfrentan en una audiencia sobre un fármaco para prevenir el nacimiento prematuro
LUNES, 17 de octubre de 2022 (HealthDay News) -- En una audiencia de tres días...
